Your browser doesn't support javascript.
loading
CAR T-cell behavior and function revealed by real-time imaging.
Espie, David; Donnadieu, Emmanuel.
Afiliación
  • Espie D; Université Paris Cité, CNRS, INSERM, Equipe Labellisée Ligue Contre le Cancer, Institut Cochin, INSERM U1016, 22 rue Méchain, F-75014, Paris, France.
  • Donnadieu E; Invectys, Paris, France.
Semin Immunopathol ; 45(2): 229-239, 2023 03.
Article en En | MEDLINE | ID: mdl-36688965
ABSTRACT
Adoptive transfer of T-cells expressing chimeric antigen receptors (CAR) has shown remarkable clinical efficacy against advanced B-cell malignancies. Nonetheless, the field of CAR T-cells is currently facing several major challenges. In particular, the CAR T-cell strategy has not yet produced favorable clinical responses when targeting solid tumors. In this context, it is of paramount importance to understand the determinants that limit the efficacy of T-cell-based immunotherapy. Characterization of CAR T-cells is usually based on flow cytometry and whole-transcriptome profiling. These approaches have been very valuable to determine intrinsic elements that condition T-cell ability to proliferate and expand. However, they do not take into account spatial and kinetic aspects of T-cell responses. In particular, in order to control tumor growth, CAR T-cells need to enter into the tumor, migrate within a complex tumor environment, and form productive conjugates with their targets. Advanced imaging techniques combined with innovative preclinical models represent promising tools to uncover the dynamics of CAR T-cells. In this review, we will discuss recent results on the biology of engineered T-cells that have been obtained with real-time imaging microscopy. Important notions have emerged from these imaging-based studies, such as the multi-killing potential of CAR T-cells. Finally, we will highlight how imaging techniques combined with other tools can solve remaining unresolved questions in the field of engineered T-cells.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Límite: Humans Idioma: En Revista: Semin Immunopathol Asunto de la revista: ALERGIA E IMUNOLOGIA / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Límite: Humans Idioma: En Revista: Semin Immunopathol Asunto de la revista: ALERGIA E IMUNOLOGIA / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY